Clinical Trials Sponsored by Danae Hamouda

Total 1306 results

Steven P. Treon, MD, PhD
Massachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaborators

Completed

Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia

Lymphoplasmacytic Lymphoma | Waldenstrom's Macroglobulinemia

United States
Versiti
Dana-Farber Cancer Institute; University of Illinois at Chicago; Medical College... and other collaborators

Unknown

Microvascular Blood Flow in Sickle Cell Anemia

Sickle Cell Disease | Sickle Cell Anemia

United States
Duke University
Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Dana-Farber... and other collaborators

Completed

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY (PROPHECY)

Prostate Cancer

United States
Beth Israel Deaconess Medical Center
Massachusetts General Hospital; Sanofi; University of Southern California; VA Boston... and other collaborators

Completed

Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles (MicroTEC)

Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; United States... and other collaborators

Unknown

Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer

Prostate Cancer

United States
Ospedale Policlinico San Martino
Dana-Farber Cancer Institute; Universita degli Studi di Genova; Sidra Medical... and other collaborators

Active, not recruiting

Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer (RENOVATE)

Breast Cancer

Italy
Lecia V. Sequist
Bristol-Myers Squibb; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical... and other collaborators

Terminated

Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy

Non-small Cell Lung Cancer

United States
Andrew E. Place, MD
University of Colorado, Denver; AbbVie; Boston Children's Hospital; Gateway for... and other collaborators

Recruiting

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Acute Lymphoblastic Leukemia, in Relapse | Therapy-Related Myelodysplastic Syndrome | Acute Leukemia of Ambiguous Lineage | Acute Leukemia of Ambiguous Lineage in Relapse | Myelodysplastic Syndromes, Previously Treated | Acute Lymphoblastic Leukemia With Failed Remission | Myelodysplastic Syndromes... and other conditions

United States
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Dana-Farber Cancer Institute; Sheba Medical Center; Shaare... and other collaborators

Recruiting

A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma

United States, Israel
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI); Dana-Farber Cancer Institute; Stanford University and other collaborators

Completed

Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women

Cigarette Smoking Behavior

United States
Dana-Farber Cancer Institute
Johns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer... and other collaborators

Recruiting

STOP-HER2: Stopping Trastuzumab in HER2+ MBC

Breast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer

United States
Children's Mercy Hospital Kansas City
Dana-Farber Cancer Institute; Duke University; University of California, San... and other collaborators

Recruiting

Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome

Stem Cell Transplant Complications | Bone Marrow Transplant Complications | Sinusoidal Obstruction Syndrome | Veno Occlusive Disease, Hepatic

United States
Syntrix Biosystems, Inc.
M.D. Anderson Cancer Center; National Cancer Institute (NCI); Massachusetts General... and other collaborators

Recruiting

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

Melanoma Stage IV | Melanoma Stage III

United States
Beth Israel Deaconess Medical Center
Rambam Health Care Campus; Dana-Farber Cancer Institute; United States Department... and other collaborators

Active, not recruiting

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

Multiple Myeloma

United States, Israel
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University; Dana-Farber Cancer Institute; Icahn School of Medicine... and other collaborators

Completed

Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time (HOTSPOT)

Oropharyngeal Cancer | Human Papillomavirus

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI); The Hospital for Sick Children; St. Jude Children... and other collaborators

Completed

A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors (PFH2)

Cancer

United States
Dana-Farber Cancer Institute
Bristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical... and other collaborators

Completed

A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer

Prostate Cancer

United States
Andrea DeCensi
Herbert Irving Comprehensive Cancer Center; Breast Cancer Research Foundation; Istituto Europeo di Oncologia and other collaborators

Not yet recruiting

Babytam vs Babyexe in Post-menopausal Women at High Risk for Breast Cancer. (BabyTears)

Breast Cancer

Italy
Brigham and Women's Hospital
National Cancer Institute (NCI); Dana-Farber Cancer Institute; University of... and other collaborators

Recruiting

A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation (Potlako+)

Neoplasms | Cervical Cancer | Breast Cancer | Hiv | Vulvar Cancer | Anal Cancer | HNSCC | Cancer Suspect

Botswana
Harvard School of Public Health (HSPH)
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Dana-Farber... and other collaborators

Completed

Reducing Skin Cancer Risk in Childhood Cancer Survivors

Skin Neoplasms

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Bayer; University of California, Los Angeles; Northwestern... and other collaborators

Completed

Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia

Lymphoplasmacytic Lymphoma | Waldenstrom's Macroglobulinemia

United States
Patrick Y. Wen, MD
Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Dana-Farber... and other collaborators

Completed

Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors (Zactima)

Glioblastoma Multiforme | Gliosarcoma

United States
University of Michigan Rogel Cancer Center
Baylor College of Medicine; Merck Sharp & Dohme LLC; Dana-Farber Cancer Institute and other collaborators

Completed

Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Kristiania University College
Memorial Sloan Kettering Cancer Center; Dana-Farber Cancer Institute; University... and other collaborators

Recruiting

Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?

Quality of Life | Fatigue | Insomnia | Hot Flashes | Depression, Anxiety

Norway
Massachusetts General Hospital
M.D. Anderson Cancer Center; National Cancer Institute (NCI); Dana-Farber Cancer... and other collaborators

Recruiting

Proton RT for the Treatment of Pediatric Rhabdomyosarcoma

Rhabdomyosarcoma

United States
Alliance Foundation Trials, LLC.
Patient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Washington... and other collaborators

Active, not recruiting

Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS (COMET)

Ductal Carcinoma in Situ | DCIS

United States
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI); Dana-Farber Cancer Institute and other collaborators

Completed

Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) (STRIDE2)

Sickle Cell Disease

United States
Patrick Y. Wen, MD
Massachusetts General Hospital; Northwestern University; Novartis; Beth Israel... and other collaborators

Completed

LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma

Malignant Glioma

United States
Alliance Foundation Trials, LLC.
Patient-Centered Outcomes Research Institute; Mayo Clinic; Dana-Farber Cancer... and other collaborators

Active, not recruiting

Electronic Patient Reporting of Symptoms During Cancer Treatment (PRO-TECT)

Metastatic Cancer

United States
University of Texas Southwestern Medical Center
National Cancer Institute (NCI); Baylor College of Medicine; University of Pennsylvania and other collaborators

Recruiting

National Liver Cancer Screening Trial (TRACER)

Liver Cirrhosis | Hepatitis B | Carcinoma, Hepatocellular | Liver Cancer

United States
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI); Dana-Farber Cancer Institute; Stanford University and other collaborators

Completed

Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches (RESIST)

Cigarette Smoking Behavior

United States
Harold J. Burstein, MD, PhD
Massachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaborators

Completed

Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer

Breast Cancer | Stage I Breast Cancer | Stage II Breast Cancer

United States
Beth Israel Deaconess Medical Center
Harvard Medical School (HMS and HSDM); National Cancer Institute (NCI); Dana-Farber... and other collaborators

Terminated

Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12

Breast Cancer

United States
Massachusetts General Hospital
University of British Columbia; Dana-Farber Cancer Institute; University of California... and other collaborators

Completed

International HIV Antiretroviral Adherence, Resistance and Survival (UARTO)

HIV/AIDS

Uganda
University Health Network, Toronto
Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Dana-Farber... and other collaborators

Active, not recruiting

Pancreatic Adenocarcinoma Signature Stratification for Treatment (PASS-01)

Pancreatic Cancer Metastatic | Pancreatic Ductal Adenocarcinoma | Advanced Pancreatic Cancer

United States, Canada
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaborators

Completed

Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer

Prostate Cancer

United States
Harold J. Burstein, MD, PhD
Beth Israel Deaconess Medical Center; Genentech, Inc.; University of California... and other collaborators

Completed

Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer

Breast Cancer

United States
Harold J. Burstein, MD, PhD
Bristol-Myers Squibb; Massachusetts General Hospital; Dana-Farber Cancer Institute and other collaborators

Completed

Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer

Breast Cancer

United States
Fondazione IRCCS Istituto Nazionale dei Tumori,...
University of Padova; Mount Sinai Hospital, Canada; Istituto Oncologico Veneto... and other collaborators

Recruiting

Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.

Pregnancy Complications | Pregnancy Loss | Desmoid | Desmoid; Abdominal

United States, Canada, France, Italy
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital; University... and other collaborators

Withdrawn

MK-2206 for Recurrent Malignant Glioma

Malignant Glioma

United States
Sabine Mueller, MD, PhD
National Cancer Institute (NCI); Dana-Farber Cancer Institute; Mithil Prasad... and other collaborators

Recruiting

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors (PNOC023)

Glioblastoma | Recurrent Ependymoma | CNS Tumor | Diffuse Midline Glioma (DMG) | Recurrent Malignant Central Nervous System Neoplasm | Spinal Cord Glioma | Central Nervous System Tumor | World Health Organization (WHO) Grade III Glioma

United States, Switzerland
St. Jude Children's Research Hospital
Baylor College of Medicine; Children's Hospital of Philadelphia; Dana-Farber... and other collaborators

Recruiting

Investigation of the Genetics of Hematologic Diseases

Myelodysplastic Syndromes | Sickle Cell Disease | Fanconi Anemia | Severe Congenital Neutropenia | Bone Marrow Failure Syndromes | Blood Coagulation Disorder | Erythrocyte Disorder | Leukocyte Disorder | Hemostasis | Dyskeratosis Congenita | Diamond-Blackfan Anemia | Congenital Thrombocytopenia | Myeloproliferative...

United States
Dana-Farber Cancer Institute
Johns Hopkins University; M.D. Anderson Cancer Center; Mayo Clinic; University... and other collaborators

Active, not recruiting

GENetic Education Risk Assessment and TEsting Study (GENERATE)

Candidates for Hereditary Pancreatic Cancer Testing

United States
Susana M. Campos, MD
Massachusetts General Hospital; Wyeth is now a wholly owned subsidiary of Pfizer and other collaborators

Completed

AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

Cervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Peritoneal Cancer

United States
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Beth... and other collaborators

Completed

Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma

Multiple Myeloma

United States
Massachusetts General Hospital
National Cancer Institute (NCI); Mayo Clinic; Washington University School of... and other collaborators

Recruiting

Proton or Photon RT for Retroperitoneal Sarcomas

Retroperitoneal Sarcoma

United States
Karen D. Wright, MD
National Cancer Institute (NCI); Pacific Pediatric Neuro-Oncology Consortium; Day One Biopharmaceuticals, Inc... and other collaborators

Active, not recruiting

DAY101 In Gliomas and Other Tumors

Low-grade Glioma

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Emory University and other collaborators

Completed

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Sickle Cell Disease | Hemoglobinopathies | Thalassemia

United States
New York Medical College
Johns Hopkins University; Baylor College of Medicine; University of California... and other collaborators

Recruiting

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease (NYMC-571)

Sickle Cell Disease

United States
Kaiser Permanente
Dana-Farber Cancer Institute; Columbia University; Emory University; University... and other collaborators

Active, not recruiting

Cancer Health Assessments Reaching Many (CHARM)

Hereditary Cancer Syndrome

United States

Clinical Trials Sponsored by Danae Hamouda

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations